Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01221298
What this trial is testing

A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)

Who this might be right for
Hepatitis CHCVChronic Hepatitis C Infection+1 more
AbbVie (prior sponsor, Abbott) 11
Large-scale testing (Phase 3)Study completedNCT03219216
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 100
Large-scale testing (Phase 3)Study completedNCT00039871
What this trial is testing

PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)

Who this might be right for
HepatitisHepatitis C, ChronicFibrosis+1 more
Merck Sharp & Dohme LLC 2,333
Not applicableStudy completedNCT00926016
What this trial is testing

Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

Who this might be right for
Chronic Hepatitis C
Brooke Army Medical Center 23
Post-approval studies (Phase 4)Study completedNCT03627299
What this trial is testing

Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors

Who this might be right for
End Stage Renal DiseaseHepatitis C
Johns Hopkins University 11
Early research (Phase 1)Study completedNCT04232514
What this trial is testing

Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects

Who this might be right for
Chronic Hepatitis C
Sunshine Lake Pharma Co., Ltd. 28
Post-approval studies (Phase 4)Study completedNCT00207363
What this trial is testing

Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC

Who this might be right for
Hepatitis C
Brooke Army Medical Center 610
Not applicableStudy completedNCT00723892
What this trial is testing

Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)

Who this might be right for
Hepatitis C, ChronicHepacivirus
Merck Sharp & Dohme LLC 614
Not applicableStudy completedNCT04198584
What this trial is testing

Study of Telemedicine Stress Management and Lifestyle Group Intervention for HCV Patients

Who this might be right for
Chronic Hepatitis C
University of North Carolina, Chapel Hill 32
Early research (Phase 1)Study completedNCT01247194
What this trial is testing

A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1

Who this might be right for
Chronic Genotype 1 Hepatitis C Virus Infection
Presidio Pharmaceuticals, Inc. 24
Large-scale testing (Phase 3)Ended earlyNCT00122629
What this trial is testing

Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders

Who this might be right for
Hepatitis C, Chronic
French National Agency for Research on AIDS and Viral Hepatitis 405
Large-scale testing (Phase 3)Study completedNCT01701401
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 870
Early research (Phase 1)Active Not RecruitingNCT02772003
What this trial is testing

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic HepatitisHepatitis C InfectionHepatocellular Carcinoma
National Cancer Institute (NCI) 33
Post-approval studies (Phase 4)Study completedNCT00957866
What this trial is testing

Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity

Who this might be right for
Chronic Hepatitis C
University of Manitoba 160
Large-scale testing (Phase 3)Study completedNCT04112303
What this trial is testing

Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 37
Testing effectiveness (Phase 2)Ended earlyNCT02293941
What this trial is testing

Liver Test Study of Using JKB-122 in Hepatitis C Virus (HCV)-Positive Patients Nonresponsive to Prior Interferon Based Therapies

Who this might be right for
Chronic Hepatitis C
TaiwanJ Pharmaceuticals Co., Ltd 54
Post-approval studies (Phase 4)Study completedNCT01770483
What this trial is testing

The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients

Who this might be right for
Hepatitis C, ChronicDIABETES MELLITUS Type 2
Services Institute of Medical Sciences, Pakistan 66
Post-approval studies (Phase 4)Study completedNCT01258101
What this trial is testing

PEGASYS (Peginterferon Alfa-2a) Plus Ribavirin in Patients With Chronic Hepatitis C (CHC), Genotype 2 or 3

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 395
Large-scale testing (Phase 3)Study completedNCT01121705
What this trial is testing

Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)

Who this might be right for
Chronic Hepatitis
Casa Sollievo della Sofferenza IRCCS 360
Not applicableStudy completedNCT02106156
What this trial is testing

Observational Study Evaluating the Quality of Pegylated Interferon Alfa-2a and Ribavirin Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologists)

Who this might be right for
Chronic Hepatitis C
Hoffmann-La Roche 10,228
Next Page